-
Click here for the February 2010 Clinical Briefs in Primary Care supplement
-
Malaria is one of the most important diagnostic considerations in febrile returned travelers and can be fatal if not appropriately diagnosed and treated.
-
In October 2009, the US FDA approved Cervarix, a bivalent vaccine containing the oncogenic HPV types 16 and 18, for the prevention of cervical cancer and precancerous lesions in females ages 10 years through 25 years.
-
A longitudinal study of hospitalized WNV patients in Houston was initiated in 2002. A total of 112 patients remain in the cohort.
-
Although generally institutions were well prepared for the H1N1 crisis, respondents to this survey said they had to neglect other medical duties, were aware of antiviral hoarding by colleagues and overall favored mandatory vaccination of health care workers, the authors of this timely report conclude.
-
In a move that could affect hospital infection prevention programs, the U.S. Occupational Safety and Health Administration is taking the first steps toward a possible airborne infectious diseases standard.
-
The Centers for Disease Control and Prevention recommends that infection preventionists implement quality improvement (QI) programs or strategies to enhance appropriate use of indwelling catheters and to reduce the risk of CA-UTI based on a facility risk assessment.
-
The Centers for Disease Control and Prevention has completed a massive update and revision of its 1981 guidelines to prevent catheter-associated urinary tract infections (CA-UTIs).
-
Surgical-site infections (SSI) significantly increase the chance of hospital readmission and can cost as much as $60,000 per patient, according to Duke University Medical Center researchers who conducted the largest study of its kind to date.
-
Citing a fatal complacency during about the same stage of the 1957 influenza pandemic, the Centers for Disease Control & Prevention is urging everyone to be vaccinated for H1N1 influenza A.